Healthcare Equipment and Supplies
Company Overview of NeoChord, Inc.
NeoChord, Inc., a medical device company, develops devices to treat mitral regurgitation. The company offers NeoChord, a disposable device that replaces damaged chordae through a small incision while the heart is beating. Its products are used to treat patients in TACT registry and non-registry centers in Europe. The company was founded in 2007 and is based in St. Louis Park, Minnesota.
5402 Parkdale Drive
St. Louis Park, MN 55416
Founded in 2007
Key Executives for NeoChord, Inc.
NeoChord, Inc. Key Developments
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact NeoChord, Inc., please visit www.neochord.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.